Clarification with respect to outcome of board meeting held on October 06, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Mardia Samyoung Capillary Tubes has decided to withdraw its earlier proposal to shift the registered office from Mumbai to Ahmedabad, reversing a decision first approved on August 30, 2025 and ratified by shareholders at the AGM on September 21, 2025. After further review, the board concluded that Mumbai offers stronger strategic and commercial benefits for the company's growth. The registered office will therefore continue to remain at A-108, 1st Floor, Chikuwadi, Western Express Highway, Andheri East, Mumbai. The current filing (October 10, 2025) is a revised version of the October 6 outcome due to a clerical error, and also notes a correction in the registered office address.
No material financial impact for shareholders — the company is simply staying put in its existing Mumbai base. The reversal of the office shift avoids any relocation disruption or costs, and preserves operational continuity.